Vaccine

Amid Rapidly Rising Bird Flu Cases, Moderna Lands $176M Worth US Government Contract For Vaccine
Groundbreaking Fentanyl Vaccine Being Developed To Prevent Fatal Overdoses, Startup Secures $10M
AstraZeneca Pulls Plug On Vaxzevria COVID-19 Vaccine Amid Surplus of Updated Vaccines
Groundbreaking Fentanyl Vaccine Being Developed To Prevent Fatal Overdoses, Startup Secures $10M
AstraZeneca Pulls Plug On Vaxzevria COVID-19 Vaccine Amid Surplus of Updated Vaccines
CureVac, GSK Partner Release Data On Influenza Vaccine Study
Marjorie Taylor Greene Faces Democratic Criticism Over 'Vulgarity' And 'Conspiracy' In Vaccine Hearing

Vaccine Recent News

Do I Need to Get A Polio Vaccine? New York Sewer Discovery Triggers Fears About Paralysis-Inducing Virus
New York officials have detected polio in the city's wastewater, suggesting the virus has been circulating in the local area.
FDA Approves New Technique To Extend Supply Of Monkeypox Vaccine: Report
A plan to extend the limited supply of monkeypox vaccine in order to provide additional doses has been approved by the Food and Drug Administration.
FDA Eyes New Vaccine Composition In Response To COVID Mutations: Here's What You Need To Know
As COVID-19 continues to mutate and form new variants, the FDA is calling on the major vaccine manufacturers to create a new composition of the vaccine for adults.
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
Novavax's COVID-19 Vaccine For Adults Over 18 Backed By FDA Advisors: What's Next?
Novavax, Inc. (NASDAQ: NVAX) announced the U.S.
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More
Here's a roundup of top developments in the biotech space over the last 24 hours:
COVID Booster Dose No Longer Required For Employees Of This Tech Giant In US Offices
Meta Platforms Inc (NASDAQ: FB) recently announced that the company no longer requires employees to have COVID-19 booster shots to enter its offices in the U.S. 
Is Novavax Turning Around? A Technical Analysis
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher Monday after the company submitted a request to the U.S Food and Drug Administration for Emergency Use Authorization of its COVID-19 vaccine, NVX-CoV2373. Novavax was up 13% at $93.70 Monday afternoon at publication.
Jiangsu Recbio Shoots To Become Hong Kong's First HPV Vaccine Stock
Key takeaways: Jiangsu Recbio has filed a second IPO application to list in Hong Kong, hoping to become the first HPV vaccine maker in the market The company was valued at around 9 billion yuan after its latest funding round By Molly Wen
BofA Downgrades CureVac On Limited 2022 Prospects
There is limited upside from CureVac BV’s (NASDAQ: CVAC) COVID-19 vaccine and there are few catalysts from the rest of the company’s pipeline in 2022, according to BofA Securities.
What The Future Might Hold For Novavax Stock
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher Thursday after Australia’s national drug regulator granted approval for the company's COVID-19 vaccine. The stock is trading below what traders call a pennant pattern and is showing uncertainty in where it could head next.
New Treatments For Opioid Addiction: Vaccine And CBD Product In Development
With drug overdoses having skyrocketed over the past two decades and deaths increased over four times in the period between 1999 and 2017, according to CDC data, it's no surprise that the number of those prone to opioid use disorder and opiate addiction is rising as well.
Apple To Require Proof Of COVID Booster Shot For Store And Corporate Employees
Apple Inc (NASDAQ: AAPL) has asked its store as well as corporate employees to get a COVID-19 booster shot. 
Novak Djokovic Leaves Australia After Losing Visa Appeal; Serbian President Says Aussies 'Humiliated Themselves'
Serbian tennis star Novak Djokovic has left Australia after losing an appeal to stay in the country and seek his tenth Australian Open championship despite being unvaccinated against COVID-19.
10 Best Performing S&P 500 Stocks Of 2021
The S&P 500 delivered one of its best years in recent history in 2021, gaining more than 27%. Most U.S. investors had a lot of winners in their portfolios this year, but some stocks certainly performed better than others. Here’s a look at the 10 best-performing stocks in the entire S&P 500 in 2021.
Novavax Falls Below Support: What Does This Mean For The Vaccine Stock?
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Monday, slightly falling below a pattern the stock has been trading in. On Thursday, the company said it expanded a license agreement for its NVX-CoV2373 recombinant nanoparticle protein-based COVID-19 vaccine with SK Bioscience Co.
8 S&P 500 Stocks Up More Than 100% In 2021
The year 2021 has featured retail trading-induced short squeezes, soaring special purpose acquisition companies (SPACs) and extreme volatility in cryptocurrency markets. Amid the many bouts of short-term mania, there are a handful of stocks in the S&P 500 Index that have more than doubled this year. 
Greatly Transformed Sinovac Set To Reawaken On Wall Street?
Key takeaways: Two key legal developments could soon pave the way for a resumption of trading in shares of Nasdaq-listed Sinovac, ending a nearly three-year suspension Company’s revenue may have risen 80-fold or more since the suspension thanks to sales of its globally accepted CoronaVac Covid-19 vaccine By Doug Young
Here's Why Moderna May Be Ready To Head Higher Again
Moderna Inc (NASDAQ: MRNA) shares are trading lower Friday after the company announced interim Phase 1 data for its mRNA flu vaccine.
Merriam-Webster Names 'Vaccine' As 2021 Word Of The Year
As the omicron variant of the coronavirus begins its sweep across the globe, Merriam-Webster has announced “vaccine” as its 2021 Word of the Year.
Moderna Up Over 8% On Strong Options Volume
Moderna Inc (NASDAQ: MRNA) is having a strong start to the week, up more than 7% Monday on heavy volume. Thus far, the stock has traded over 11 million shares versus its 10 day average of 8 million.
Could This Vaccine News Help Moderna Stock Recover?
Moderna Inc (NASDAQ: MRNA) shares are trading higher Friday after the FDA authorized its booster dose of COVID-19 vaccine in the U.S. for adults 18 years and older.
Inovio Pharmaceuticals Sees A Bounce Off Support After COVID-19 Vaccine News
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Tuesday after the FDA removed a hold on the company’s late-stage COVID-19 vaccine trial in the U.S. Inovio Pharmaceuticals is trading up 4.60% at $7.05 at market close Tuesday.